No description availableFDA approves Moderna's new lower-dose COVID-19 vaccineRead full article: FDA approves Moderna's new lower-dose COVID-19 vaccineThe Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.
No description availableSenators press Moderna CEO on COVID-19 vaccine price hikeRead full article: Senators press Moderna CEO on COVID-19 vaccine price hikeModerna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price.
No description availableModerna misses on 3Q, shaves 2022 vaccine expectationsRead full article: Moderna misses on 3Q, shaves 2022 vaccine expectationsSupply problems have again forced Moderna to delay some COVID-19 vaccine deliveries, a move that surprised Wall Street and contributed to a disappointing third quarter.
No description availableModerna lowers forecast for 2021 COVID-19 vaccine deliveriesRead full article: Moderna lowers forecast for 2021 COVID-19 vaccine deliveriesModerna is scaling back expectations for the number of COVID-19 vaccine deliveries it expects to make this year and the revenue it will record from them.
